• No products in the cart.
  • News
  • MyCELLINK
  • Support
  • Contact us
  • Language
    • English
    • 中文
    • 日本語
    • 대한민국
  • No products in the cart.
  • Bioprinters
    • Overview
    • Extrusion-based
      • BIO X™
      • BIO X6™
      • INKREDIBLE+™
    • Light-based
      • BIONOVA X
      • Quantum X bio
      • Lumen X+
    • Biodispenser
      • BIO CELLX
  • Biomaterials
    • Overview
    • Bioink components
    • Ready-to-use bioinks
    • Tissue-specific bioinks
    • Bioink accessories
    • Cells & media
  • Resources
    • Application notes
    • White papers
    • The Culture Blog
    • Initiatives
      • TumourPrint Project
    • Customer spotlights
    • Publications
    • Collaborator data
  • Events
    • Trade shows
    • Webinars
  • Company
    • About CELLINK
    • Careers
    • Sustainability
      • Overview
      • Sustainable Tissue Engineering Practices
    • Contact us
    • Support
    • News
  • Shop
  • Get a quote
  • Bioprinters
    • Overview
    • Extrusion-based
      • BIO X™
      • BIO X6™
      • INKREDIBLE+™
    • Light-based
      • BIONOVA X
      • Quantum X bio
      • Lumen X+
    • Biodispenser
      • BIO CELLX
  • Biomaterials
    • Overview
    • Bioink components
    • Ready-to-use bioinks
    • Tissue-specific bioinks
    • Bioink accessories
    • Cells & media
  • Resources
    • Application notes
    • White papers
    • The Culture Blog
    • Initiatives
      • TumourPrint Project
    • Customer spotlights
    • Publications
    • Collaborator data
  • Events
    • Trade shows
    • Webinars
  • Company
    • About CELLINK
    • Careers
    • Sustainability
      • Overview
      • Sustainable Tissue Engineering Practices
    • Contact us
    • Support
    • News
  • Shop

  • News
  • MyCELLINK
  • Support
  • Contact us
  • Sustainability
  • Get a quote

Newsroom

  • All news
  • 3d bioprinting
  • Bioink
  • Biotech
  • Company news
  • Industry News
  • Uncategorized
May 6, 2022 | Company news

BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology

May 5, 2022 | Company news

CELLINK Announces CTR Scientific as Exclusive Distributor in Mexico

April 21, 2022 | Company news

CELLINK Enters a Collaboration Agreement with Zoan BioMed to Develop Bioinks for Bone Regeneration and Coral Restoration

April 18, 2022 | Company news

CELLINK Inaugurates Good Manufacturing Practice (GMP) Lab at Their Kallebäck Location to Enable Clinical Grade Bioinks for Human Applications.

April 14, 2022 | 3d bioprinting

Happy Easter 2022!

April 13, 2022 | Industry News

A Swedish Initiative to Address the Gaps in Organ Shortage

March 1, 2022 | Company news

Launching the BIO CELLX

February 16, 2022 | Company news

Upscaling production of CollPlant’s regenerative breast implants using our bioprinting technologies

January 21, 2022 | Industry News

First pig-to-human heart transplant

December 15, 2021 | Company news

CELLINK and Nanoscribe join forces to launch the Quantum X bio

December 10, 2021 | Industry News

CELLINK Bioprinters Used by CTIBIOTECH to Produce World’s First Immunized Human Skin Model

November 24, 2021 | Industry News

CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing

October 14, 2021 | Company news

BICO strengthens IP portfolio with two additional patents for 3D bioprinting

September 22, 2021 | 3d bioprinting

BICO Launches 3D Bioprinting Contract Research Offering From CELLINK, MatTek and Visikol

June 28, 2021 | Company news

CELLINK has entered into an agreement to acquire Discover Echo Inc.

May 20, 2021 | Company news

CELLINK has acquired Visikol

May 19, 2021 | Company news

CELLINK has entered into an agreement to acquire Nanoscribe

April 14, 2021 | 3d bioprinting

CELLINK receives the prestigious gold award for the BIO X6 and wins two design excellence awards for the C.WASH and UP.SIGHT at the iF Design Awards 2021

April 14, 2021 | Industry News

CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments

March 23, 2021 | 3d bioprinting

BIO X6 wins prestigious Red Dot Design Award for outstanding design quality

March 15, 2021 | 3d bioprinting

CELLINK launches the BIO MDX Series, a scaled-up revolution in biomedical manufacturing

March 15, 2021 | Company news

CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion

March 15, 2021 | Company news

CELLINK has entered into an agreement to acquire MatTek, the global leader in in-vitro technology and alternative drug testing models

February 15, 2021 | Company news

CELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis

January 28, 2021 | 3d bioprinting

CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery

January 28, 2021 | Company news

CELLINK launches UP.SIGHT, a rapid, all-in-one imager and single-cell dispenser that offers double assurance of clonality

January 19, 2021 | Company news

CELLINK to bring Livecyte high content live cell imager to a wider audience

November 11, 2020 | Company news

CELLINK will help develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joint s as part of the TRIANKLE project

October 22, 2020 | Company news

CELLINK launches CASY

October 22, 2020 | Company news

CELLINK launches C.WASH

October 22, 2020 | Company news

Q4 19/20: Strong organic growth and important strategic acquisition under continued challenging conditions

September 9, 2020 | Uncategorized

At CELLINK, we’re proud to support a tight-knit family that is passionate, persistent and inspired. Across almost 200 employees and offices located all over the world, we strive to maintain our unique culture that empowers each member of the team. But don’t just take our word for it! We decided to ask around and find […]

September 9, 2020 | Uncategorized

Printing cells with the Electromagnetic Droplet Printhead

September 2, 2020 | Company news

The REPAIR project aims to develop a new approach and clinically applicable method in cardiac contraction assistance. Current medical or surgical treatments cannot restore muscular contractility in heart failure and atrial fibrillation, two of the most common and serious cardiac diseases. A revolutionary approach would be to use smart materials to support or restore cardiac mechanical […]

CELLINK have been granted funding totalling €3,910,000 from the EU as a part of the Horizon 2020 program. CELLINK’s portion of the grant is €270,000

August 19, 2020 | Company news

CELLINK has entered into an agreement to acquire precision dispensing company Scienion Ag

August 14, 2020 | 3d bioprinting

Partnership with Carcinotech to advance 3D-bioprinting technology for cancer research

August 9, 2020 | 3d bioprinting

Engineering a 3D human myocardial tissue model

July 21, 2020 | Company news

CELLINK and Kugelmeiers Ltd. announce strategic partnership for 3D printing cell spheroids

June 10, 2020 | Bioink

Lonza and CELLINK Join Forces to Offer Complete 3D Cell Culture Workflows

May 14, 2020 | 3d bioprinting

CELLINK announces collaboration with AstraZeneca to utilize CELLINKs’ 3D-bioprinting technology for liver organoid culture

April 29, 2020 | Company news

CELLINK Participates on EFN Financial News

April 21, 2020 | 3d bioprinting

Rapid Fabrication of Ready-to-Use Gelatin Scaffolds with Prevascular Networks Using Alginate Hollow Fibers as Sacrificial Templates

Logotype_RGB_Cellink_Neg.png
Keep up with the latest bioprinting news by signing up for our emails
SUBSCRIBE
Sign up to our mailing list to stay updated on the latest CELLINK news, product launches and events.

Contact us

U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
APAC: +65 8750 2284

sales@cellink.com

Navigation

About us
Careers
Sustainability
MyCELLINK
3D bioprinters
Biomaterials
Shop

Policies

Supplier Code of Conduct
Internal Code of Conduct
Whistleblower/Speak-up channel

CELLINK is a part of the Bio-convergence revolution. Our products and services combine the power of biology, engineering and computer science to create the future of health.

Read more at BICO.com
  • Cookie Policy
  • Privacy Policy
Menu
  • Cookie Policy
  • Privacy Policy
Linkedin Instagram Facebook Twitter Youtube
Copyright © 2022 CELLINK - All rights reserved.
BIO CELLX
BIO CELLX
See a video on how the system works in practice

Get the link to the full video below, or watch the abridged version on our Youtube channel.

BIO X6 - Demo

BIO X6 - Demo